Ascendis Pharma AS (NAS:ASND)
$ 137.5 -2.81 (-2%) Market Cap: 8.39 Bil Enterprise Value: 8.62 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 71/100

Ascendis Pharma A/S at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 04:55PM GMT
Release Date Price: $102.56 (+2.50%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Okay. Let's go ahead and get started. This is the fireside chat with Ascendis Pharma. Thank you for joining us. Before we get started, I need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley user's disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representatives.

And I'll turn it over to Tim Lee from Ascendis Pharma to read disclosures from their standpoint.

Timothy J. Lee;S;Senior Director of IR
Ascendis Pharma A

/-

Thank you. We may make forward-looking comments during this presentation. Actual results may differ materially from those expressed or implied and you should not place undue reliance on these statements. For information concerning the factors that can cause actual results to differ materially, please see the Risk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot